AIM2 deficiency reduces the development of hepatocellular carcinoma in mice. Issue 11 (9th October 2018)
- Record Type:
- Journal Article
- Title:
- AIM2 deficiency reduces the development of hepatocellular carcinoma in mice. Issue 11 (9th October 2018)
- Main Title:
- AIM2 deficiency reduces the development of hepatocellular carcinoma in mice
- Authors:
- Martínez‐Cardona, Claudia
Lozano‐Ruiz, Beatriz
Bachiller, Victoria
Peiró, Gloria
Algaba‐Chueca, Francisco
Gómez‐Hurtado, Isabel
Such, José
Zapater, Pedro
Francés, Rubén
González‐Navajas, José Manuel - Abstract:
- Abstract : Chronic liver inflammation is crucial in the pathogenesis of hepatocellular carcinoma (HCC). Activation of the inflammasome complex is a key inflammatory process that has been associated with different liver diseases, but its role in HCC development remains largely unexplored. Here we analyzed the impact of different inflammasome components, including absent in melanoma 2 (AIM2) and NOD‐like receptor family pyrin domain containing 3 (NLRP3), in the development of diethylnitrosamine (DEN)‐induced HCC in mice. Genetic inactivation of AIM2, but not NLRP3, reduces liver damage and HCC development in this model. AIM2 deficiency ameliorates inflammasome activation, liver inflammation and proliferative responses during HCC initiation. We also identified that AIM2 is highly expressed in Kupffer cells, and that AIM2‐mediated production of IL‐1β by these cells is enhanced after DEN‐induced liver damage. Our data indicate that AIM2 promotes inflammation during carcinogenic liver injury and that it contributes to genotoxic HCC development in mice, thereby recognizing AIM2 as a potential therapeutic target in this disease. Abstract : What's new? Chronic liver inflammation is crucial in the pathogenesis of hepatocellular carcinoma (HCC), but the role of the inflammasome complex in HCC development remains largely unexplored. Here, the authors demonstrate that the inflammasome‐related receptor absent in melanoma 2 (AIM2), but not NLRP3, contributes to the development ofAbstract : Chronic liver inflammation is crucial in the pathogenesis of hepatocellular carcinoma (HCC). Activation of the inflammasome complex is a key inflammatory process that has been associated with different liver diseases, but its role in HCC development remains largely unexplored. Here we analyzed the impact of different inflammasome components, including absent in melanoma 2 (AIM2) and NOD‐like receptor family pyrin domain containing 3 (NLRP3), in the development of diethylnitrosamine (DEN)‐induced HCC in mice. Genetic inactivation of AIM2, but not NLRP3, reduces liver damage and HCC development in this model. AIM2 deficiency ameliorates inflammasome activation, liver inflammation and proliferative responses during HCC initiation. We also identified that AIM2 is highly expressed in Kupffer cells, and that AIM2‐mediated production of IL‐1β by these cells is enhanced after DEN‐induced liver damage. Our data indicate that AIM2 promotes inflammation during carcinogenic liver injury and that it contributes to genotoxic HCC development in mice, thereby recognizing AIM2 as a potential therapeutic target in this disease. Abstract : What's new? Chronic liver inflammation is crucial in the pathogenesis of hepatocellular carcinoma (HCC), but the role of the inflammasome complex in HCC development remains largely unexplored. Here, the authors demonstrate that the inflammasome‐related receptor absent in melanoma 2 (AIM2), but not NLRP3, contributes to the development of chemically‐induced HCC in mice. The data show that AIM2 is highly expressed and functional in Kupffer cells, promotes inflammasome activation in the liver, and enhances inflammatory and proliferative responses during HCC‐associated liver damage. Thus, the study highlights a previously unrecognized role for AIM2 in promoting chemical hepatocarcinogenesis that could have important translational implications. … (more)
- Is Part Of:
- International journal of cancer. Volume 143:Issue 11(2018)
- Journal:
- International journal of cancer
- Issue:
- Volume 143:Issue 11(2018)
- Issue Display:
- Volume 143, Issue 11 (2018)
- Year:
- 2018
- Volume:
- 143
- Issue:
- 11
- Issue Sort Value:
- 2018-0143-0011-0000
- Page Start:
- 2997
- Page End:
- 3007
- Publication Date:
- 2018-10-09
- Subjects:
- AIM2 -- inflammasome -- HCC -- diethylnitrosamine -- inflammation
Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ijc.31827 ↗
- Languages:
- English
- ISSNs:
- 0020-7136
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8791.xml